Resistance to
M
yeloid differentiation primary-response gene 88 (MyD88) is an adaptor protein necessary for signal transduction of the IL-1R/IL-18R family and most Toll-like receptors (TLRs) (1, 2) . Myd88 Ϫ/Ϫ mice have defective proinflammatory cytokine responses, in particular production of the Th1 differentiation factor IL-12, and have increased susceptibility when challenged with a variety of bacterial and eukaryotic pathogens, including Listera monocytogenes (3, 4) , Mycobacterium tuberculosis (5), Leishmania major (6) , and Toxoplasma gondii (7) . Consistent with its role in IL-12 responses, Myd88 Ϫ/Ϫ mice repeatedly immunized with a T. gondii-derived antigen (8) are unable to establish a Th1 response, and thus a Th2 response predominates. For these reasons, it has been postulated that Myd88 Ϫ/Ϫ mice have defects in innate pathogen recognition affecting IL-12 responses, which results in nonprotective adaptive immunity and increased susceptibility to intracellular pathogens (6) .
During toxoplasmosis, the generation of Th1 effector responses has been shown to be strictly MyD88-dependent (7, 9) . MyD88-dependent TLR11 participates in T. gondii resistance by recognition of a pathogen-derived profilin, but, unlike Myd88 Ϫ/Ϫ mice, Tlr11 Ϫ/Ϫ mice survive acute toxoplasmosis (9) . Furthermore, TLR1, TLR2, TLR4, TLR6, TLR9, IL-1, and IL-18, all of which require MyD88 for signaling, are individually not required for control of this infection (7, (10) (11) (12) (13) . Thus, it remains unclear what pattern-recognition or cytokine receptors require MyD88 either singly or collectively for pathogen control.
Although much evidence implicates MyD88 as a key signaling component of innate responses, this molecule also is expressed in T cells. In Myd88 Ϫ/Ϫ mice, a primary Th1 response to ovalbumin can be induced after regulatory T cell depletion. Nevertheless, primary and secondary immunization fail to establish T cell memory (14) . Pasare and Medzhitov (14) propose that this lack of Th1 memory is due to defects in T cell differentiation or survival in the absence of MyD88-dependent signals. However, it is unclear whether deficient Th1 memory formation is due to the absence of an uncharacterized MyD88-dependent extrinsic signal from antigen-presenting cells or whether, instead, MyD88 provides T cell-intrinsic signals required for optimal function. Relevant to the latter possibility, we recently identified an MyD88-dependent PI3K-signaling pathway in CD4 ϩ T cells that enhances survival and a T celldependent antibody response (15) .
In this study, we demonstrate that T cell expression of MyD88 is necessary for resistance to T. gondii. Bone marrow chimeras were generated to specifically evaluate the role of MyD88 in T cells under noncompetitive conditions during an in vivo adaptive response. In reconstituted mice, T cells lacked MyD88, but MyD88-dependent innate responses were intact. Upon challenge with T. gondii, these chimeric mice were found to be more susceptible to infection, which was associated with severe toxoplasmic encephalitis and reduced antigen-specific IFN-␥ production independent of IL-1R and IL-18R signaling. Our observations indicate a requirement for MyD88 in T cell-mediated resistance to a pathogen even in the setting of an intact innate response. Fig. 6 ]. Despite exogenous IL-12 enhancing a Th1 response in Myd88 Ϫ/Ϫ mice, and reciprocally suppressing a Th2 response, these effects were nonprotective during T. gondii infection. These data strongly suggest that the abnormal response of Myd88 Ϫ/Ϫ mice to T. gondii is not merely due to deficient induction of IL-12.
Results

A Model in
In light of our previous studies showing altered responses of MyD88-deficient T cells (15), we considered whether the remarkable susceptibility of Myd88 Ϫ/Ϫ mice to T. gondii might reflect a T cell-intrinsic requirement for MyD88 for control of this pathogen. To specifically evaluate the role of MyD88 in T cells under noncompetitive conditions, bone marrow chimeras were generated whose T cells lacked MyD88, but that had intact MyD88-dependent innate immune responses (TMyd88 Ϫ/Ϫ chimeric mice). As illustrated in Fig. 1A , marrow cells from mice deficient in the ␣/␤ T cell receptor (Tcr␣ Ϫ/Ϫ ) and Myd88 Ϫ/Ϫ mice were mixed in a 3:1 ratio, respectively, and used to reconstitute irradiated Tcr␣ Ϫ/Ϫ recipients. Tcr␣ Ϫ/Ϫ mice were used as recipients to ensure that the entire ␣/␤ T cell compartment was derived from the bone marrow graft. Thus, the T cell compartment in reconstituted TMyd88 Ϫ/Ϫ chimeric mice is solely derived from Myd88 Ϫ/Ϫ precursors, whereas the non-T cell hematopoietic compartment is predominantly Myd88 ϩ/ϩ (at least 75%). To control for conditioning manipulations, sham chimeric mice were generated in an analogous manner by using a marrow mixture from Tcr␣ Ϫ/Ϫ mice and Myd88 ϩ/ϩ littermates (TMyd88 ϩ/ϩ control mice).
Twelve weeks after transplant, T cells were purified from TMyd88 Ϫ/Ϫ chimeric mice, and the absence of MyD88 protein was confirmed by immunoblot (Fig. 1B) . In addition, TMyd88 Ϫ/Ϫ chimeric mice reconstituted with congenic bone marrow precursors similarly showed all T cells to be derived from CD45.1xMyd88 Ϫ/Ϫ cells, whereas B cells demonstrated CD45 isoform chimerism in the predicted proportion (Fig. 1C) . Flow cytometry of the reconstituted hematopoietic cells found a similar distribution of CD4 ϩ and CD8 ϩ T cells and B cells in the spleen and lymph nodes of TMyd88 Ϫ/Ϫ chimeric mice compared with wild-type mice (data not shown).
To evaluate innate responses in TMyd88 Ϫ/Ϫ chimeric mice, we first used CpG DNA, which activates APCs via TLR9 in an MyD88-dependent manner. In contrast to B cells from Myd88 Ϫ/Ϫ mice, the majority of B cells from TMyd88 Ϫ/Ϫ chimeric mice were CpG-responsive as measured by CD86 up-regulation (Fig. 1D) . The innate response in TMyd88 Ϫ/Ϫ chimeric mice was next evaluated by challenge with a T. gondii-derived antigen extract (STAg). The response to STAg is MyD88-dependent and results in the production of IL-12 (9) . As expected, Myd88 Ϫ/Ϫ mice were unresponsive to i.p. injection of STAg, but TMyd88 Ϫ/Ϫ chimeric mice responded robustly as measured by serum IL-12p40 (Fig.  1E) . As an additional test of the innate immune compartment, we injected mice with LPS, which induces TLR4/MyD88-dependent production of proinflammatory cytokines. Unlike Myd88 Ϫ/Ϫ mice, TMyd88
Ϫ/Ϫ chimeric mice given a lethal dose of LPS succumbed within 72 h, as did MyD88-sufficient controls (SI Fig. 7) .
Taken together, these data show TMyd88 Ϫ/Ϫ chimeric mice and their reconstituted hematopoietic APCs have intact innate responses to pathogen-associated molecules. In this chimeric model, under noncompetitive conditions, T cell responses are not limited by detectable deficits in innate recognition, thus providing an opportunity to specifically evaluate the role of MyD88 in T cells during an adaptive response.
T Cell Expression of MyD88 Is Required for Resistance to T. gondii.
Using TMyd88
Ϫ/Ϫ chimeric mice, we next determined whether T cell expression of MyD88 is necessary for resistance to T. gondii. Strikingly, all TMyd88 Ϫ/Ϫ chimeric mice succumbed to infection by day 30 and had significantly increased mortality compared with TMyd88 ϩ/ϩ control mice (P Ͻ 0.0001) ( Fig. 2A ). TMyd88 ϩ/ϩ control mice survived Ͼ30 days after infection, with a median survival of 62 days. However, as observed previously (17), they exhibited somewhat reduced resistance compared with wild-type mice (Fig. 2 A) .
Examination of peritoneal exudative cells (PECs) in TMyd88 Ϫ/Ϫ chimeric mice on day 7 of infection found only rare parasite-infected cells similar to MyD88-sufficient mice (Fig.  2B ), indicating acute control of the pathogen at the inoculation site. This finding was in contrast to PECs from unmanipulated Myd88 Ϫ/Ϫ mice, which had much larger numbers of parasitized cells. Furthermore, measurement of IL-12p40 in sera 5 days after infection revealed a comparable proinflammatory response in TMyd88 Ϫ/Ϫ chimeric mice and MyD88-sufficient controls (Fig.  2C ). This finding was in contrast to sera from unmanipulated Myd88 Ϫ/Ϫ mice, which had minimal IL-12p40 responses after infection. Flow-cytometry analysis of lymphoid tissue (mesenteric, para-aortic, and spleen) from TMyd88 Ϫ/Ϫ chimeric mice and MyD88-sufficient controls revealed a similar percentage of mature dendritic cells as measured by CD86 expression (Fig.  2D ). These data indicate that, despite their increased susceptibility to disease, TMyd88 Ϫ/Ϫ chimeric mice mount an innate response to T. gondii comparable to MyD88-sufficient controls.
In infected mice, toxoplasmic encephalitis is the major cause of morbidity and mortality (18) . Concordant with their increased susceptibility, the brains of TMyd88 Ϫ/Ϫ chimeric mice killed near median survival (days 25-27 after infection) demonstrated pa- renchymal regions of necrosis (Fig. 3A) associated with free tachyzoites (seen at higher power) (data not shown). In comparison, TMyd88 ϩ/ϩ control mice killed near median survival (days 60-62 after infection) demonstrated more focal cellular infiltrates associated with bradyzoite tissue cysts (Fig. 3B) . Analysis of brain-derived mononuclear cells (BMNCs) on day 23 of infection revealed similar T cell numbers within the brains of TMyd88 Ϫ/Ϫ chimeric mice and controls (Fig. 3C ). This finding indicated that the increased susceptibility of TMyd88 Ϫ/Ϫ chimeric mice to toxoplasmic encephalitis was not due to quantitative differences in the T cell infiltrate. Furthermore, consistent with the histopathological findings, TMyd88 Ϫ/Ϫ chimeric mice brains had an increased parasite burden compared with controls (Fig. 3D) . Collectively, these data indicate that TMyd88 Ϫ/Ϫ chimeric mice have increased susceptibility to disease and an increased parasite burden. Given their intact innate immune responses, these findings suggest an impaired adaptive response during T. gondii infection. (19, 20) . Consistent with reduced survival, sera obtained from TMyd88 Ϫ/Ϫ chimeric mice on days 8 and 23 of infection had less IFN-␥ than MyD88-sufficient controls (Fig. 4A) . To further evaluate the antigenspecific T cell response in this model, splenocytes were isolated from mice on days 8 and 23 of infection and cultured with STAg. Cell cultures from TMyd88 Ϫ/Ϫ chimeric mice produced less IFN-␥ compared with those from MyD88-sufficient controls (Fig. 4B) . Because TMyd88 Ϫ/Ϫ chimeric mice infected with T. gondii developed advanced brain pathology (Fig. 3A) , we examined the T cell response within this organ. Similar to antigenspecific responses of spleen-derived cells, cultures of BMNCs from TMyd88 Ϫ/Ϫ chimeric mice produced less IFN-␥ in the presence of STAg (Fig. 4C) .
To confirm these observations, splenocytes isolated from mice on day 23 of infection were CFSE-labeled and cultured with STAg. Antigen-specific CD4 ϩ T cell proliferation and effector response were evaluated by CFSE dilution and intracellular IFN-␥ staining, respectively. As shown in Fig. 4D , TMyd88 Ϫ/Ϫ chimeric mice had less IFN-␥ ϩ responding CD4 ϩ T cells compared with controls. We considered the possibility that Myd88 Ϫ/Ϫ T cells primed in TMyd88
Ϫ/Ϫ chimeric mice during the immune response to T. gondii may have an increased propensity for cell death in culture. Nonetheless, as measured by flow cytometry using exclusion of the vital stain 7-amino-actinomycin D (7-AAD), the survival of Myd88 Ϫ/Ϫ CD4 ϩ T cells from infected TMyd88 Ϫ/Ϫ chimeric mice was comparable to controls (Fig. 4E) . Thus, diminished IFN-␥ in these cultures and the observation of reduced responder frequency are unlikely to be caused by increased T cell death ex vivo. Thus, in both lymphoid and brain 
tissue, TMyd88
Ϫ/Ϫ chimeric mice infected with T. gondii generate fewer antigen-specific IFN-␥-producing T cells.
To evaluate whether reduced IFN-␥ production in infected TMyd88 Ϫ/Ϫ chimeric mice was associated with poor T cell responses in vivo, animals were pulsed with BrdU on days 5 and 6 of infection and killed on day 8. These experiments revealed comparable levels of T cell proliferation in TMyd88 Ϫ/Ϫ chimeric mice and controls (Fig. 4F ). In addition, there were similar numbers of T cells in spleens on day 7 of infection (TMyd88 Ϫ/Ϫ : CD4 ϩ 9.5 Ϯ 1.6 ϫ 10 6 , CD8 ϩ 5.6 Ϯ 1.3 ϫ 10 6 ; TMyd88 ϩ/ϩ : CD4 ϩ 8.8 Ϯ 1.5 ϫ 10 6 , CD8 ϩ 5.3 Ϯ 0.9 ϫ 10 6 ; data pooled from three experiments of a least three mice each). These data suggest that MyD88 deficiency limited to the T cell compartment alters the relative levels of IFN-␥ produced in response to T. gondii without affecting the expansion or survival of responding T cells, in turn affecting the ability to maintain prolonged resistance.
Deficient IL-1R/IL-18R Signaling in T Cells Is Not the Cause of Increased
Susceptibility of TMyd88 ؊/؊ Chimeric Mice. MyD88 is required for signaling via multiple T cell-expressed TLRs (15, (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) , which may play a role in the immune response to T. gondii. MyD88 also is used for downstream signaling via IL-1R and IL-18 R, raising the possibility that TMyd88 Ϫ/Ϫ chimeric mice have increased susceptibility due to defects in these pathways. However, other groups have reported that IL-18-deficient mice (11) and mice lacking caspase-1, which is responsible for converting precursors of IL-1␤ and IL-18 into an active form, have unimpaired resistance to T. gondii (12) . To evaluate whether our results ref lected impairment in a pathway initiated by IL-18-independent engagement of the IL-18R (31) or IL-1-independent engagement of the IL-1R, we challenged IL-18R-deficient and IL-1R-deficient mice with T. gondii. Consistent with previous reports, neither of these transgenic strains had increased susceptibility to T. gondii (data not shown). Thus, in TMyd88 Ϫ/Ϫ chimeric mice, the absence of signals mediated by IL-1R or IL-18R within T cells is unlikely to be the cause of reduced resistance.
Considering the potential for functional redundancy within the IL-1R/IL-18R receptor family, it remained possible that the increased susceptibility in TMyd88 Ϫ/Ϫ chimeric mice was due to disruption of both IL-1R and IL-18R signals, perhaps superimposed on the experimental conditions of bone marrow reconstitution. Unfortunately, mice with a targeted mutation in both the IL-1R and IL-18R genes are unavailable, and the close proximity of these genes within the IL-1R/IL-18R cluster on chromosome 1 make crossing the Il1r1 Ϫ/Ϫ and IL18r1 Ϫ/Ϫ strains impractical. Therefore, in a manner analogous to that used in previous experiments (Fig. 1 A) , chimeric mice were generated by using a marrow mixture from Tcr␣ Ϫ/Ϫ mice and Il18r1 Ϫ/Ϫ mice (TIl18r1 Ϫ/Ϫ chimeric mice). TIl18r1 Ϫ/Ϫ chimeric mice and controls were infected with T. gondii and were administered recombinant IL-1 receptor antagonist (IL-1Ra) daily. The dose of IL-1Ra given (500 mg/kg) was sufficient to rescue 80% of wild-type mice from a highly lethal challenge with 40 mg/kg LPS (SI Fig. 8 ). Because prolonged administration of IL-1Ra was impractical, we used parasite burden and IFN-␥ production as surrogate measures in place of survival for the response to T. gondii, and we examined these parameters on day 23, the time just preceding mortality in TMyd88 Ϫ/Ϫ chimeric mice. On day 23 of infection, the brains of TIl18r1 Ϫ/Ϫ chimeric mice given IL-1Ra had markedly less parasite DNA compared with TMyd88 Ϫ/Ϫ chimeric mice, with levels comparable to wild-type reconstitution controls (Fig. 5A) . Splenocytes isolated from mice on day 23 of infection and cultured with STAg revealed that IFN-␥ production was only in part dependent on IL-18R and was independent of IL-1R (Fig. 5 B and C) . These data further support that the T cell-intrinsic role of MyD88 during the response to T. gondii is independent of IL-1R and IL-18R signaling.
Discussion
The superfamily of transmembrane receptors defined by the intracellular Toll/IL-1 receptor (TIR) domain plays a major role in the early immune response. This superfamily can be divided into two groups based on the extracellular domain of the receptors: those having an Ig-like domain, like the IL-1R/IL-18R family; and those having a leucine-rich repeat motif, such as TLRs (32) . The IL-1R/IL-18R family includes the IL-1 receptor type I (IL-1RI), IL-1R accessory protein, the decoy receptor IL-1R type II, the IL-18 receptors (IL-18R␣ and IL-18R␤), the putative regulatory receptor T1/ST2, and other poorly characterized receptors, including IL-1R-related protein 2 (IL-1Rrp2). The IL-1R/IL-18R family and all TLRs, except TLR3, signal through a pathway that uses the adaptor protein, MyD88. MyD88 is one of five TIR domain-containing adaptors; as such, it links these receptors to other downstream signaling molecules, like the IL-1R-associated kinase family (2). However, MyD88 also interacts with proteins that lack TIR domains, such as PI3K (15, 33) , IFN-␥ receptor 1 (34), IFN regulatory factor (IRF) 1 (35), IRF5 (36) , and IRF7 (37) .
Because activated CD4 ϩ T cells contain a MyD88-dependent signaling pathway that affects T cell function and survival (15), we considered whether MyD88 directly mediates signals in T cells important for resistance to T. gondii, a pathogen to which resistance is highly dependent on MyD88 and cell-mediated immunity (7, 9, 10) . To evaluate the role of MyD88 in T cells under noncompetitive conditions, we generated bone marrow chimeras in which T cells lacked MyD88 but MyD88-dependent innate immune responses were shown to be intact. Upon challenge with T. gondii, these chimeric mice were more susceptible to disease, establishing that T cell expression of MyD88 is necessary for prolonged resistance to this pathogen.
Necropsy of TMyd88 Ϫ/Ϫ chimeric mice moribund with T. gondii infection revealed brain histopathology consistent with poor parasite control. This finding appeared similar to that described in infected mice after T cell depletion or treatment with monoclonal antibody to IFN-␥ (38, 39) . Consistent with these findings, we found that TMyd88 Ϫ/Ϫ chimeric mice had less IFN-␥-producing CD4 ϩ T cells during the immune response to T. gondii. Given that IL-1 is a ubiquitously expressed proinflammatory cytokine that costimulates T cells (40) and IL-18 is a major inducer of IFN-␥ production, we considered the possibility that the simultaneous disruption of both of these pathways in TMyd88 Ϫ/Ϫ chimeric mice was the cause of increase susceptibility and decreased IFN-␥ production. By generating TIl18r1 Ϫ/Ϫ chimeric mice and treating with high doses of IL-1Ra during infection, we evaluated this possibility under the experimental conditions of bone marrow reconstitution. It was not surprising that chimeras with T cells lacking IL-18R␣ produced less antigen-specific IFN-␥ ex vivo; however, infected TIl18r1 Ϫ/Ϫ chimeric mice treated with IL-1Ra demonstrated a greater degree of resistance to infection (as assessed by parasite burden) than TMyd88 Ϫ/Ϫ chimeric mice. Thus, our findings support the role of a MyD88-dependent signaling pathway in T cells that affects function, separate from IL-1R/IL-18R-dependent effects. Although the receptors T1/ST2 and IL-1Rrp2 are thought to be MyD88-dependent, these receptors do not bind IL-1 or IL-18 (32, 41) , and their role in T. gondii infection is uncharacterized.
The importance of MyD88 for TLR signaling within cells of the innate immune system and B cells is well established. The triggering of TLRs on antigen-presenting cells allows for infectious non-self-discrimination and initiates events important to adaptive immunity, such as costimulatory molecule expression and enhanced antigen presentation (42) . In addition to TLR expression in innate immune cells, several reports demonstrate TLR expression in murine and human T cells (21-25, 27, 29, 30, 43, 44) , and TLR agonists directly costimulate T cell activation and modulate effector function (15, (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) . Whether TLR signaling within T cells affects the in vivo adaptive response to infection has not been evaluated. Our results provide in vivo evidence in support of a T cell-intrinsic MyD88-dependent pathway that directly modulates effector function. At present, it cannot be determined from our experiments whether this requirement for MyD88 in T cells is to enable TLR signaling or another known function of the molecule, such as MyD88-dependent posttranscriptional regulation (34) , or perform a function that has not yet been described. Nonetheless, our data indicate a role for MyD88 in T cell-mediated resistance to a pathogen independent of the well established role for MyD88 in linking innate and adaptive immunity by APC-mediated pathogen recognition. Together these findings imply that the increased susceptibility of Myd88 Ϫ/Ϫ mice upon challenge with certain pathogens may in part be due to abnormal cell-mediated immunity caused by the lack of MyD88-dependent signaling in T cells, a possibility that has largely been underappreciated.
Materials and Methods
Mice. Myd88 Ϫ/Ϫ mice were provided by S. Akira (Osaka University, Osaka, Japan), and other strains were purchased from The Jackson Laboratory. All mice were on the B6 background. Animals were housed within the University of Pennsylvania University Laboratory Animal Resources facility and treated according to approved protocols.
Experimental
Infection. An i.p. injection of 20 cysts of T. gondii ME49 strain, isolated from brains of infected CBA/CaJ mice, was used for infection. In some experiments, infected Myd88 Ϫ/Ϫ mice were given 250 ng recombinant mouse IL-12 (R&D Systems) or PBS i.p. 3 h postinfection and then daily (16) . PECs were obtained from day 7-infected mice and used to prepare cytospins, which were stained for histological analysis. The mean percentage of cells infected with T. gondii was determined by counting 500 cells per smear. For measurement of parasite burden, the 35-fold repetitive T. gondii B1 gene was amplified by real-time PCR as described (45) .
Generation of Mixed Bone Marrow Chimeric Mice.
Marrow from femur and tibia was obtained by flushing with a needle. Erythrocytes were lysed from the marrow suspension, and T-cells were depleted (anti-CD90 MicroBeads; Miltenyi Biotec). Prepared marrow cells from Tcr␣ Ϫ/Ϫ and Myd88 Ϫ/Ϫ mice were combined in a 3:1 ratio, respectively. This mixture was used to generate TMyd88 Ϫ/Ϫ chimeric mice. Marrow cells from Tcr␣ Ϫ/Ϫ mice and Myd88 ϩ/ϩ littermates were combined in the same way to generate TMyd88 ϩ/ϩ control mice. Recipient mice were irradiated with 1,000 rads, followed 8 -18 h later by i.v. injection of 2-3 ϫ 10 6 marrow cells. In all experiments, mice were used after 12 weeks, at which time the hematopoietic compartment was determined reconstituted by flow cytometry.
Immunoblotting. T cells were isolated (Pan-T cell isolation kit; Miltenyi Biotec) to Ͼ90% purity. Cell lysates were loaded at 2 ϫ 10 6 cell equivalents per well and resolved on an SDS/10% PAGE gel. Proteins were probed with rabbit anti-mouse MyD88 (FL-296; Santa Cruz Biotechnologies) at a 1:500 dilution. Analysis of Immune Responses. STAg was prepared as described (46) . Then, 20 g was given to mice i.p., and serum was obtained after 3 h for IL-12p40 ELISA. In other studies, 1 mg LPS (Escherichia coli 055:B5; Sigma-Aldrich) was given to mice i.p., and 72-h survival was determined. To assess splenocyte responses, cells were cultured alone or with the addition of 1 M CpG DNA. After 24 h, the cells were analyzed by FACS for B cell expression of CD86. To assess ex vivo responses, erythrocyte-depleted splenocytes were cultured for 72 h in the presence or absence of 25 g/ml STAg. Cell-free supernatants were collected for cytokine measurement by ELISA after 72 h incubation. The 7-AAD staining solution (BD PharMingen) was used according to the manufacturer's instructions. For intracellular cytokine staining, splenocytes were cultured with or without 25 g/ml STAg for 48 h; washed; resuspended in media containing 2 M monensin (BD PharMingen), 5 ng/ml phorbol 12-myristate 13-acetate, and 500 ng/ml ionomycin; and cultured for an additional 5 h. Cells were then washed, stained with surface antibodies, and fixed and permeabilized by using the Cytofix/Cytoperm kit (BD PharMingen). BMNCs were prepared as described (47) .
Statistical Analysis. The Mantel-Haenzel log-rank test was used to determine the statistical significance of survival data. P Ͻ 0.05 was considered significant.
